Actionable news
All posts from Actionable news
Actionable news in VRTX: Vertex Pharmaceuticals Incorporated,

Perilous Reversal Watch: Vertex Pharmaceuticals (VRTX)

Trade-Ideas LLC identified Vertex Pharmaceuticals ( VRTX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Vertex Pharmaceuticals as such a stock due to the following factors:

  • VRTX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $221.4 million.
  • VRTX has traded 403,121 shares today.
  • VRTX is down 3.1% today.
  • VRTX was up 8.5% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VRTX with the Ticky from Trade-Ideas. See the FREE profile for VRTX NOW at Trade-Ideas More details on VRTX: Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. Currently there are 11 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold. The average volume for Vertex Pharmaceuticals has been 2.8 million shares per day over the past 30 days. Vertex has a market cap of $20.7 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.47 and a short float of 2.9% with 2.49 days to cover. Shares are down 27.4% year-to-date as of the...